Elicio Therapeutics

1 follower


Elicio is committed to transforming the lives of patients and their families by re-engineering the body’s immune response to cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

Robert Connelly

Collapse
Peter C. DeMuth
Chief Scientific Officer
Brian Piekos
Chief Financial Officer
Megan Filoon
General Counsel, Secretary & Compliance Officer
Christopher Haqq
EVP, Head of R&D & CMO
Esther Welkowsky
SVP, Clinical Development
Thian Kheoh
SVP, Biometrics
Joy Seymour
VP & Head of Regulatory Affairs
Steve Flores
VP, Supply Chain
Kelli Arriola
Senior Manager, Clinical Sample Logistics
Michael Divecchia
SVP, Operations & Human Resources